Edoardo Cignoli : Celgene Earnings Shrink On Rising Research-And-Development Costs

Celgene said its fourth-quarter profit shrank 19% as the biopharmaceutical firm's higher research-and-development costs offset stronger revenue.



via WSJ.com: US Business http://ift.tt/1iPBQn6